Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia.
Sausan A MoharramKinjal ShahFatima KhanumLars RönnstrandJulhash U KaziPublished in: Blood cancer journal (2019)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.